Latest Vivo Capital, LLC Stock Portfolio
$1.20Billion– No. of Holdings #46
Vivo Capital, LLC Performance:
2026 Q1: 17.56%YTD: 17.56%2025: 125.64%
Performance for 2026 Q1 is 17.56%, and YTD is 17.56%, and 2025 is 125.64%.
About Vivo Capital, LLC and 13F Hedge Fund Stock Holdings
Vivo Capital, LLC is a hedge fund based in Palo Alto, CA. On 2026-05-20, the fund reported it's updated stock portfolio. In the 13F Holdings report, Vivo Capital, LLC reported an equity portfolio of $1.2 Billions as of 31 Mar, 2026.
The top stock holdings of Vivo Capital, LLC are ERAS, PRAX, TERN. The fund has invested 16.3% of it's portfolio in ERASCA INC and 9.1% of portfolio in PRAXIS PRECISION MEDICINES.
The fund managers got completely rid off CIDARA THERAPEUTICS, INC. (CDTX), AVADEL PHARMACEUTICALS PLC and CYTOMX THERAPEUTICS INC (CTMX) stocks. They significantly reduced their stock positions in VIRIDIAN THERAPEUTICS INC (VRDN), COGENT BIOSCIENCES INC (COGT) and TERNS PHARMACEUTICALS INC (TERN). Vivo Capital, LLC opened new stock positions in SENSEI BIOTHERAPEUTICS INC (SNSE), ARRIVENT BIOPHARMA INC and AN2 THERAPEUTICS INC (ANTX). The fund showed a lot of confidence in some stocks as they added substantially to ERASCA INC (ERAS), CORVUS PHARMACEUTICALS HOLDINGS (CRVS) and BRIGHT MINDS BIOSCIENCES INC (DRUG).
The top stock holdings of Vivo Capital, LLC are ERAS, PRAX, TERN. The fund has invested 16.3% of it's portfolio in ERASCA INC and 9.1% of portfolio in PRAXIS PRECISION MEDICINES.
The fund managers got completely rid off CIDARA THERAPEUTICS, INC. (CDTX), AVADEL PHARMACEUTICALS PLC and CYTOMX THERAPEUTICS INC (CTMX) stocks. They significantly reduced their stock positions in VIRIDIAN THERAPEUTICS INC (VRDN), COGENT BIOSCIENCES INC (COGT) and TERNS PHARMACEUTICALS INC (TERN). Vivo Capital, LLC opened new stock positions in SENSEI BIOTHERAPEUTICS INC (SNSE), ARRIVENT BIOPHARMA INC and AN2 THERAPEUTICS INC (ANTX). The fund showed a lot of confidence in some stocks as they added substantially to ERASCA INC (ERAS), CORVUS PHARMACEUTICALS HOLDINGS (CRVS) and BRIGHT MINDS BIOSCIENCES INC (DRUG).
Vivo Capital, LLC Equity Portfolio Value
Last Reported on: 20 May, 2026
Vivo Capital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Vivo Capital, LLC made a return of 17.56% in the last quarter. In trailing 12 months, it's portfolio return was 161.17%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| sensei biotherapeutics inc | 22,758,100 |
| arrivent biopharma inc | 20,438,100 |
| veradermics inc | 18,945,000 |
| an2 therapeutics inc | 10,785,400 |
| onkure therapeutics inc | 7,980,720 |
| alx oncology holdings inc | 6,385,350 |
| satellos bioscience inc | 4,580,940 |
| compass pathway plc | 1,106,000 |
New stocks bought by Vivo Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| erasca inc | 31.04 |
| corvus pharmaceuticals holdings | 25.56 |
| bright minds biosciences inc | 11.08 |
| dbv technologies sa | 8.37 |
| praxis precision medicines | 3.04 |
Additions to existing portfolio by Vivo Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| viridian therapeutics inc | -83.08 |
| cogent biosciences inc | -82.4 |
| terns pharmaceuticals inc | -75.04 |
| geron corp | -68.15 |
| soleno therapeutics inc | -67.05 |
| dyne therapeutics inc | -40.44 |
| abivax sa - adr | -33.33 |
| aclaris therapeutics, inc. | -25.00 |
Vivo Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| cytomx therapeutics inc | -12,288,500 |
| avadel pharmaceuticals plc | -57,842,500 |
| palisade bio inc | -5,389,910 |
| abeona therapeutics, inc. | -9,711,300 |
| verastem inc | -8,542,360 |
| silence therapeutics plc | -6,721,160 |
| cidara therapeutics, inc. | -211,319,000 |
| zenas biopharma inc | -30,990,400 |
Vivo Capital, LLC got rid off the above stocks
Sector Distribution
Vivo Capital, LLC has about 78.5% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 78.5 |
| Others | 21.5 |
Market Cap. Distribution
Vivo Capital, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- SMALL-CAP
- UNALLOCATED
- MICRO-CAP
- NANO-CAP
| Category | % |
|---|---|
| MID-CAP | 40.7 |
| SMALL-CAP | 26.2 |
| UNALLOCATED | 21.5 |
| MICRO-CAP | 6.5 |
| NANO-CAP | 5.1 |
Stocks belong to which Index?
About 47.4% of the stocks held by Vivo Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 52.6 |
| RUSSELL 2000 | 47.4 |
Vivo Capital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Vivo Capital, LLC
Vivo Capital, LLC has 46 stocks in it's portfolio. About 59.3% of the portfolio is in top 10 stocks. PEPG proved to be the most loss making stock for the portfolio. ERAS was the most profitable stock for Vivo Capital, LLC last quarter.
Last Reported on: 20 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABEO | abeona therapeutics, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACRS | aclaris therapeutics, inc. | 2.08 | 6,666,670 | 25,000,000 | reduced | -25.00 | ||
| ALXO | alx oncology holdings inc | 0.53 | 3,184,710 | 6,385,350 | new | |||
| ANTX | an2 therapeutics inc | 0.90 | 3,153,640 | 10,785,400 | new | |||
| BOLT | bolt therapeutics inc | 0.02 | 72,414 | 292,553 | unchanged | 0.00 | ||
| CDTX | cidara therapeutics, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CMPS | compass pathway plc | 0.09 | 200,000 | 1,106,000 | new | |||
| CMPX | compass therapeutics inc | 4.20 | 9,545,470 | 50,495,500 | unchanged | 0.00 | ||
| COGT | cogent biosciences inc | 1.35 | 422,300 | 16,254,300 | reduced | -82.4 | ||
| CRVS | corvus pharmaceuticals holdings | 3.41 | 2,805,820 | 41,049,100 | added | 25.56 | ||
| CTMX | cytomx therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DBVT | dbv technologies sa | 4.63 | 2,667,570 | 55,725,500 | added | 8.37 | ||
| DRUG | bright minds biosciences inc | 3.38 | 557,172 | 40,656,800 | added | 11.08 | ||
| DSGN | design therapeutics inc | 1.43 | 1,612,900 | 17,161,300 | unchanged | 0.00 | ||
| DTIL | precision biosciences inc | 0.00 | 4,675 | 25,713 | unchanged | 0.00 | ||
| DYN | dyne therapeutics inc | 2.35 | 1,557,470 | 28,236,900 | reduced | -40.44 | ||
| ERAS | erasca inc | 16.34 | 12,151,500 | 196,611,000 | added | 31.04 | ||
| GERN | geron corp | 1.07 | 8,671,800 | 12,921,000 | reduced | -68.15 | ||
| KTTA | pasithea therapeutics corp | 0.13 | 2,100,000 | 1,557,780 | unchanged | 0.00 | ||
| MLTX | moonlake immunotherapeutics | 1.55 | 1,000,000 | 18,640,000 | unchanged | 0.00 | ||